Needham & Company Boosts Alnylam (ALNY) PT to $28 on Medicines Co. Deal
Tweet Send to a Friend
Needham & Company raised its price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) from $20 to $28 after the company reached ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
